Coronavirus Cases India: India's recovery rate is at 62.61 per cent.
Coronavirus Live Updates: India's coronavirus tally stands at 11,55,191 cases after 37,148 new infections were recorded in the last 24 hours, the Union Health Ministry said this morning, adding that the country recorded 587 deaths linked to the highly contagious since yesterday. More than 7.2 lakh patients have recovered so far. A total of 28,084 COVID-19 linked deaths have been recorded since the beginning of the pandemic. India is the third worst-hit country by the pandemic after the United States and Brazil.
Maharashtra continues to report the highest number of cases, followed by Andhra Pradesh, Tamil Nadu, Karnataka, Gujarat and West Bengal.
Meanwhile, trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK. The vaccine AZD1222 had a favourable response in the first phase of clinical trials. It did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
Here are the Updates on Coronavirus (COVID-19) Cases:
Trump Tweets Photo Of Himself With Mask: "Nobody More Patriotic Than Me"
US President Donald Trump promised Monday to resume televised coronavirus briefings and finally spoke out in favor of mask-wearing -- a marked change of tune as polls show him headed for election disaster, reports AFP.
Over 11.55 Lakh COVID-19 Cases So Far, 28,084 Deaths, 62.7% Recovery Rate
India's coronavirus tally stands at 11,55,191 cases after 37,148 new infections were recorded in the last 24 hours, the Union Health Ministry said this morning, adding that the country recorded 587 deaths linked to the highly contagious since yesterday.
1,43,81,303 samples tested for COVID-19 up to July 20.
UK Secures 90 Million Doses Of Potential Coronavirus Vaccines
Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech, and French group Valneva, the business ministry said on Monday, reports Reuters
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, reports Reuters.
Coronavirus: Delhi Appears To Have Hit The Peak, Say AIIMS Director
Delhi reported less than 1,000 new COVID-19 cases for the first time in seven weeks on Monday, as AIIMS Director Randeep Guleria said the national capital seems to have hit the peak but cautioned against any lowering of guard, reports PTI.
Indian Medical Experts Welcome Oxford Trial Results For COVID Vaccine
Medical experts in India on Monday hailed the results of Oxford University's early-stage human trials for a COVID-19 vaccine, with some saying it''s the "most scientifically done" among all such exercises, while others expressing hope that the final trials will "bear fruit". From clinicians to pathology experts, doctors in the country feel the Oxford trials have been the "most transparent" one by far, reports PTI.
Oxford Vaccine Partner Plans Trials In India, Manufacturing Soon
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK. The vaccine AZD1222 had a favourable response in the first phase of clinical trials. It did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
Read here 
